Avian İnfluenza; Diyarbakır Dicle Universitesi Tıp Fakültesi Çocuk Kliniği Deneyimi
Abstract
Keywords
References
- http://www.saqlik.qov.tr
- http://www.who.int/csr/disease/avian influenza/countrv/cases table 2006 02 6. Hill G, Cihlar T, Oo C, Ho ES, Prior K, Wiltshire 20/en/index.html
- http://www.klimik.org.tr
- Kaji M., Neurominidase inhibitor, anti- influenzal agent-mechanism of action and how to use clinically. Nippon Rinsho.61:1975-9, 2003
- de Jong MD, Thanh, TT, Khanh, TH, Hien, VM, Smith, GJD, Chau, NV, et al. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med 353:2667-2672, 2005 H, Barrett J, Liu B, Ward P. The anti-influenza drug oseltamivir exhibits low potential to induce pharmacokinetic drug interactions via renal secretion--correlation of in vivo and in vitro studies. Drug Metabolism and Disposition 301:13-19, 2002.
- Rossi S, editor. Australian Medicines Handbook 2006. Adelaide: Australian Medicines Handbook; 2006.
Details
Primary Language
Turkish
Subjects
-
Journal Section
-
Authors
Bünyamin Dikici
This is me
Aşkın Hekimoğlu
This is me
Şehmus Sevinç
This is me
Ali Güneş
This is me
Mehmet Ali Taş
This is me
Publication Date
December 1, 2005
Submission Date
-
Acceptance Date
-
Published in Issue
Year 2005 Volume: 7 Number: 3
